Grow Healthy
With Dr. Sally's
"Vital Signs" Blog
Since IBS, or irritable bowel syndrome, affects nearly 45 million people in the United States chances are that you, or someone you know, struggles with gas, bloating, cramping, and diarrhea or constipation. The cause of IBS is multifactorial, meaning that a number of triggers may contribute to this dysfunction.
According to a study published this summer in the American Journal of Gastroenterology, people who use omeprazole are more likely to get COVID-19. (1, 2) The long-term, twice-daily use of PPIs doubles the odds of testing positive COVID-19, even after taking into account a range of sociodemographic, lifestyle and clinical variables. Omeprazole is in a class of drugs called “Proton Pump Inhibitors”, or PPIs, which reduce stomach acid output by 99%. PPIs include brands such as Nexium, Prilosec and Prevacid.
